Medicago Inc.

This article is about the biotech company. For the plant genus, see Medicago. For other uses, see Medicago (disambiguation).

Medicago Inc.
Company typePrivate
IndustryBiotechnology
Founded1999
FounderLouis-Philippe Vézina Edit this on Wikidata
Defunct2023
HeadquartersQuebec City, Quebec, Canada
Key people
Toshifumi Tada (President & CEO)
Websitemedicago.com (archived)

Medicago Inc. was a Canadian biotechnology company focused on the discovery, development, and commercialization of virus-like particles using plants as bioreactors to produce proteins, candidate vaccines, and medications. By using live plant leaves as hosts in the discovery and manufacturing process, the Medicago "Proficia" technology intended to create a rapid, high-yield system for its product candidates. Privately owned by a subsidiary of Mitsubishi Tanabe Pharma, Medicago and its product development programs were terminated by Mitsubishi in February 2023.[1]

The main clinical targets for Medicago product candidates were antiviral vaccines and antibody therapeutics.[2] The company's name was derived from the Latin word for alfalfa, which was the first plant the company used to develop its technologies.[3] Medicago technologies evolved from research at the Laval University and Agriculture and Agri-Food Canada in the 1990s.

N. benthamiana plant used by Medicago as a "minifactory" for rapid production of VLPs for a potential COVID-19 vaccine

History

A research partnership was formed between Laval University and Agriculture Canada in 1997. This would go on to be incorporated in 1999 as Medicago, licensing that technology researched in the partnership, from Agriculture Canada and Université Laval.[4]

In September 2013, Philip Morris International acquired a 40% stake in Medicago, the remaining 60% being acquired by Mitsubishi Tanabe Pharma Corporation and other Mitsubishi Group companies, in a joint purchase.[5][6]

The company had a Phase III clinical trial underway in 2020 for its candidate to prevent seasonal influenza.[2]

For its COVID-19 vaccine, Medicago grew its virus-like particles in the Australian weed, Nicotiana benthamiana.[7] In July 2020, the company began a Phase I clinical trial on its candidate vaccine for COVID-19 disease, coVLP,[8][9] which advanced to a Phase II-III trial in Canada and the United States during November 2020.[10][11] The Canadian government invested $173 million into Medicago to support development of the Covifenz vaccine and help expand its production facility.[12] In December 2021, the company announced that its CoVLP vaccine candidate exhibited 71% efficacy and no adverse effects in a multinational, Phase III clinical trial.[13] In February 2022, Health Canada authorized use of CoVLP (brand name Covifenz) for preventing COVID-19 infection in adults 18 to 64 years old.[14]

In July 2022, the Canadian federal government determined it would not consider buying the shares owned by Medicago's parent company, tobacco company Philip Morris International, to overcome the problem of the World Health Organization accepting any products from tobacco concerns.[15]

In December 2022, Philip Morris was bought out by Mitsubishi, acquiring a 100% stake in the company.[16]

Termination

In February 2023, Mitsubishi Chemical Corporation decided to shut down the company due to the changing landscape of COVID-19 vaccines and the marketplace, and the low commercial prospects of the company.[1][17]

Technology

Nicotiana benthamiana, leaf

The Medicago technology used plants as bioreactors to produce proteins for vaccine and protein-based therapeutic candidates.[18] The plant-based production platform was intended to be accurate and rapid to shorten product development time and prevent the risk of mutation.[18]

Medicago used its proprietary Proficia technology, which is a possible alternative to traditional egg-based methods for producing virus-like particles (VLPs) used to manufacture vaccine candidates.[19][18] Typically, licensed influenza vaccines are manufactured using embryonated chicken eggs.[20] With living plants as hosts, Proficia technology used VLP production as antigens in plant leaves, providing a flexible, high-yield system with potential to produce test material within the growth period of plants (one month).[18]

The steps of the technology are:

  1. synthesis – VLP genes are produced from a known viral sequence, requiring no live virus;
  2. infiltration – using a vacuum infiltration method, the VLP genes are introduced into plant leaves;
  3. incubation – the plants containing the genetic material are incubated over days in specific chambers for protein production to grow VLPs;
  4. harvest – leaves are collected then processed to extract VLPs;
  5. purification – clinical-grade material is purified to prepare for human testing.[18]

VLPs serve as potential vaccines by mimicking the natural structure and function of viruses, enabling recognition by the immune system.[18] However, by absence of the main virus genetic material, VLPs are non-infectious and unable to replicate like a virus does in vivo, thereby evoking an immune response similar to a natural infection, but without the associated illnesses.[18]

COVID-19 vaccine

Main article: CoVLP
Further information: COVID-19 vaccine

The lead COVID-19 vaccine candidate, CoVLP, by Medicago, was a coronavirus VLP grown in the Australian weed, Nicotiana benthamiana.[7][8][11]

Medicago was developing the COVID-19 vaccine candidate in collaboration with the governments of Canada and Quebec,[3] and by using an adjuvant manufactured by GlaxoSmithKline.[21]

Phase I research

As of August 2020, the Medicago vaccine candidate was being evaluated for safety, toxicity, and immune response in a Phase I clinical trial at two locations in Quebec.[9] In October 2020, the Government of Canada awarded Medicago a contract of up to $173 million to advance the company's COVID-19 vaccine candidate.[22]

Phase II-III research

In November 2020, Medicago-GSK started Phase II-III clinical trials for their COVID-19 vaccine candidate.[11][23]

As of January 2021, the Phase III trial was enrolling participants toward the total goal of 30,612, with each volunteer receiving two injections 21 days apart in an amount of 3.75 micrograms of CoVLP each time.[24] The Phase III study is scheduled to conclude in April 2022.[24] In December 2021, the CoVLP candidate showed 71% efficacy and safety in preliminary results from the Phase III trial.[13]

Authorization

In February 2022, Medicago and GlaxoSmithKline received authorization for CoVLP from Health Canada as an approved vaccine for preventing COVID-19 infection in adults 18 to 64 years old.[14] The brand name for CoVLP is Covifenz.[25]

In March 2022, the first Canadian-made COVID-19 vaccine produced by Medicago was rejected by the World Health Organization due to the tobacco company Philip Morris International owning a stake in the company.[26] The UN agency has a strict policy about engagement with the tobacco industry.[15]

Withdrawal and corporate termination

Due to substantial competition in the global vaccine market and low demand for Covifenz, Mitsubishi announced in February 2023 that Covifenz and Medicago, Inc. would be terminated.[1]

Aramis Biotechnologies

Aramis Biotechnologies[27] was set up as a successor company to Medicago during 2023, acquiring intellectual property and equipment, in agreement with Mitsubishi Chemical Group.[28][29]

See also

References

  1. ^ a b c "Quebec-based COVID-19 vaccine maker Medicago to shut down". CBC News. 2 February 2023. Retrieved 3 February 2023.
  2. ^ a b "Medicago - Pipeline". Medicago Inc. 2020. Retrieved 3 August 2020.
  3. ^ a b "Medicago - About us". Medicago Inc. 2020. Archived from the original on 11 October 2020. Retrieved 16 July 2020.
  4. ^ Medicago (2022). "Our History". Medicago.
  5. ^ "Philip Morris International Inc. Update on Holding of Medicago Inc". Philip Morris. Businesswire. 18 September 2013.
  6. ^ "Mitsubishi Tanabe Pharma to take 60 pct stake in Canada's Medicago". Reuters. 12 July 2013.
  7. ^ a b St. Philip, Elizabeth; Favaro, Avis; MacLeod, Meredith (14 July 2020). "The hunt for a vaccine: Canadian company begins human testing of COVID-19 candidate". CTV News. Retrieved 14 July 2020.
  8. ^ a b Vishwadha Chander (14 July 2020). "Canada's Medicago begins human trials of plant-based COVID-19 vaccine". National Post. Reuters. Retrieved 14 July 2020.
  9. ^ a b "Safety, Tolerability and Immunogenicity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years". ClinicalTrials.gov. Retrieved 14 July 2020.
  10. ^ Clinical trial number NCT04636697 for "Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults" at ClinicalTrials.gov
  11. ^ a b c "Medicago and GSK start of Phase II/III clinical trials of adjuvanted COVID-19 vaccine candidate". Drug Discovery World. 13 November 2020. Retrieved 29 November 2020.
  12. ^ anerjee, Sidhartha B (3 February 2023). "CBC".
  13. ^ a b Christy Somos (7 December 2021). "Canadian-made, plant-based COVID-19 vaccine sees positive Phase 3 results". CTV News. Retrieved 7 December 2021.
  14. ^ a b "Health Canada authorizes Medicago COVID-19 vaccine for adults 18 to 64 years of age". Health Canada, Government of Canada. 24 February 2022. Retrieved 24 February 2022.
  15. ^ a b "Feds won't buy tobacco company's stake in Medicago to free up COVID vaccines: minister". Global News. The Canadian Press. Retrieved 16 July 2022.
  16. ^ Peggy Lam (29 December 2022). "Big Tobacco's divestment from Quebec's Medicago 'a step in the right direction' for its COVID vaccine". CBC News.
  17. ^ "Quebec COVID-19 vaccine manufacturer Medicago to cease operations". CTV News. The Canadian Press. 2 February 2023.
  18. ^ a b c d e f g "Medicago - Technologies". Medicago Inc. 2020. Archived from the original on 26 January 2021. Retrieved 2 August 2020.
  19. ^ "New tobacco-based flu vaccine offers promising alternative to egg-based versions, says GlobalData analyst". Manufacturing Chemist. 11 March 2016. Retrieved 3 August 2020.
  20. ^ "Tobacco-based influenza vaccine hailed a promising alternative to egg-based methods". The Pharma Letter. 3 November 2016. Retrieved 2 August 2020.
  21. ^ "GSK partners with Medicago to develop plant-based Covid-19 vaccine". Pharmaceutical Technology. 8 July 2020. Retrieved 3 August 2020.
  22. ^ "Prime Minister announces funding to advance the development of Canadian COVID‑19 vaccine technologies". Prime Minister of Canada. 23 October 2020. Archived from the original on 18 August 2022. Retrieved 21 August 2022.
  23. ^ "GSK, Medicago launch phase 2/3 clinical trials of plant-derived COVID-19 vaccine". PMLive. 13 November 2020. Retrieved 16 November 2020.
  24. ^ a b Medicago (18 November 2020). "Randomized, Observer-Blind, Placebo-Controlled, Phase 2/3 Study to Assess the Safety, Efficacy, and Immunogenicity of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults 18 Years of Age or Older". Clinical Trials. Retrieved 26 November 2020.
  25. ^ "Medicago and GSK announce the approval by Health Canada of COVIFENZ, an Adjuvanted Plant-Based COVID-19 Vaccine". Medicago. 24 February 2022. Archived from the original on 24 February 2022. Retrieved 24 February 2022.
  26. ^ Ahmar Khan. "WHO rejects Medicago's COVID-19 vaccine due to ties to tobacco giant". Global News. Retrieved 16 July 2022.
  27. ^ "Aramis Biotechnologies | Plant-based vaccine technology".
  28. ^ "Quebec vaccine maker Medicago to relaunch under new agreement". 8 December 2023.
  29. ^ "Agreement reached on retaining Medicago's strategic research and development assets in Canada and recovering payment from Medicago". 8 December 2023.

Read other articles:

Guano

Disambiguazione – Se stai cercando altri significati, vedi Guano (disambigua). Questa voce o sezione sull'argomento sostanze chimiche non cita le fonti necessarie o quelle presenti sono insufficienti. Puoi migliorare questa voce aggiungendo citazioni da fonti attendibili secondo le linee guida sull'uso delle fonti. Le isole del guano a Chincha, Perù. 21 febbraio 1863 Il guano (dallo spagnolo huano, a sua volta dal quechua wanu) è costituito dagli escrementi degli uccelli marini e de...

 

منتخب هونغ كونغ لاتحاد الرغبي

منتخب هونغ كونغ لاتحاد الرغبي اللقب Dragons بلد الرياضة الصين  تاريخ التأسيس 9 مارس 1969  الموقع الرسمي الموقع الرسمي،  والموقع الرسمي  الألوان الرئيسية الألوان الثانوية تصنيف الرغبي العالمي [الإنجليزية] الحالي 24 (في 29 يوليو 2019) أعلى تصنيف 21 (2018) أدنى تصنيف 34 (2010) مشاركة ...

 

Perang Bali I

Intervensi Belanda di Bali (1846)Perang Bali IBatalyon VII maju dalam serangan ke BaliTanggal7 Mei 1848-1850LokasiBali, IndonesiaHasil Kemenangan Belanda yang menentukan. Belanda menguasai Bali Utara.Pihak terlibat Hindia Belanda Kerajaan Buleleng Kerajaan KarangasemTokoh dan pemimpin LaksDa.Engelbertus Batavus van den BoschKekuatan 23 kapal perang, 17 kapal, 1.280 serdadu, 115 senapan +10.000 prajurit lbsIntervensi Belanda di Bali Bali Utara (1846) Bali Utara (1848) Bali (1849) Bali (1858) L...

Wali kota

Kapten Soedjono AJ Wali Kota pertama di Samarinda Kal-Tm dari tahun 1 Januari 1960 hingga tahun 1961 Wali kota adalah kepala daerah kota. Munisipalitas adalah kota yang berada di daerah yang dikepalai oleh seorang kepala daerah yaitu wali kota yang memiliki area di dalam kota. Dari tahun 2005 pemilihan umum untuk menentukan kepala daerah dilakukan dengan cara langsung melalui tahapan pemilihan umum. Untuk menjadi seorang kepala daerah ada 2 cara yang biasa dilakukan yaitu dengan pencalonan ol...

 

Dataran lava

Tanah tandus dataran lava di Reykjanes, Islandia Pengawagasan dataran lava Holuhraun dengan pancuran lava di Kawah Baugur, Islandia, pada September 2014 Dataran lava (disebut juga lapisan lava atau lapangan lava) adalah aliran lava datar yang membentang luas. Bentang alam ini terdiri dari lava basal encer pada umumnya. Dataran lava dapat membentang luas hingga puluhan kilometer, bahkan ratusan kilometer. Cakupan wilayah ini dapat terlihat jelas dari udara atau dari foto satelit, yaitu dataran...

 

Cyril V. Pink

British obstetrician and writer (1894-1965) Cyril V. PinkBorn1894Died1965Occupation(s)Obstetrician, writer Cyril Valentine Pink (1894–1965) M.R.C.S., L.R.C.P. was a British obstetrician, naturopath, Theosophist, and vegetarianism activist. Pink was an early medical advocate of natural childbirth. He was the co-founder of Stonefield Maternity Home and was a disciple of Maximilian Bircher-Benner. Biography Pink qualified MRCS and LRCP in 1917 from St Thomas' Hospital.[1] He was House ...

Howard Beach–JFK Airport station

New York City Subway station in Queens New York City Subway station in Queens, New York Howard Beach–JFK Airport   New York City Subway rapid transit stationAirTrain JFK people mover stationView of the subway platforms and mezzanine at nightStation statisticsAddress159th Avenue & 103rd StreetQueens, NY 11414BoroughQueensLocaleHoward BeachCoordinates40°39′37″N 73°49′49″W / 40.6604°N 73.8303°W / 40.6604; -73.8303DivisionB (IND, formerly LIRR R...

 

Velveta Golightly-Howell

First Black female prosecutor in Colorado Velveta Golightly-HowellBorn1957Tuscaloosa, AlabamaAlma materTuskegee Institute, University of Colorado Law SchoolSpouseJohn L. Howell Velveta Golightly-Howell (born 1957) was Colorado's first Black female prosecutor.[1] Biography Velveta Golightly was born in 1957 in Tuscaloosa, Alabama to parents Lonnie and Marie Golightly.[1][2] Golightly-Howell was among the first Black students to integrate public schools in Alabama.&...

 

Carolina Panthers

Carolina Panthers Musim saat iniDidirikan 1993Bermain di Bank of America StadiumKantor pusat di Charlotte, North Carolina Carolina Panthers helmetCarolina Panthers logoHelmLogoAfiliasi liga National Football League (1995–sekarang) National Football Conference (1995–present) NFC West (1995–2001) NFC South (2002–present) Seragam saat iniWarna timBlack, Panther Blue, Silver, White        MaskotSir PurrPersonelPemilikDavid TepperPresidenTom GlickPelatih utamaRon Ri...

Pelé

Artikel ini perlu diterjemahkan dari bahasa Inggris ke bahasa Indonesia. Artikel ini ditulis atau diterjemahkan secara buruk dari Wikipedia bahasa Inggris. Jika halaman ini ditujukan untuk komunitas bahasa Inggris, halaman itu harus dikontribusikan ke Wikipedia bahasa Inggris. Lihat daftar bahasa Wikipedia. Artikel yang tidak diterjemahkan dapat dihapus secara cepat sesuai kriteria A2. Jika Anda ingin memeriksa artikel ini, Anda boleh menggunakan mesin penerjemah. Namun ingat, mohon tidak men...

 

Louis Carrogis Carmontelle

French painter Louis Carrogis CarmontelleSelf-portrait, 1762.BornLouis Carrogis Carmontelle(1717-08-15)15 August 1717Paris, FranceDied26 December 1806(1806-12-26) (aged 89)Paris, FranceNationalityFrenchKnown forPainting, watercolor paintingMovementRococo Louis Carrogis Carmontelle (15 August 1717 – 26 December 1806) was a French dramatist, painter, architect, set designer, author, and designer of one of the earliest examples of the French landscape garden, Parc Monceau in Paris. H...

 

Numero complesso

Un numero complesso è definito come un numero della forma x + i y {\displaystyle x+iy} , con x {\displaystyle x} e y {\displaystyle y} numeri reali e i {\displaystyle i} una soluzione dell'equazione x 2 = − 1 {\displaystyle x^{2}=-1} detta unità immaginaria. I numeri complessi sono usati in tutti i campi della matematica, in molti campi della fisica (notoriamente in meccanica quantistica), nonché in ingegneria (specialmente in elettronica, telecomunicazioni ed elettrotecnica) per la...

Michael Stuhlbarg

Michael StuhlbargMichael Stuhlbarg di acara Penghargaan Artios Casting Society of America tahun 2016Lahir5 Juli 1968 (umur 55)Long Beach, California, Amerika SerikatAlmamaterJuilliard SchoolPekerjaanAktorTahun aktif1996–sekarangSuami/istriMai-Linh Lofgren Michael Stuhlbarg (/ˈstuːlˌbɑːrɡ/; lahir 5 Juli 1968)[1] merupakan seorang aktor Amerika Serikat. Ia berperan sebagai profesor universitas yang bermasalah Larry Gopnik dalam film A Serious Man, sebagai pemimpin org...

 

Pertimbangan-Pertimbangan perihal Pemerintahan Polandia

Jean-Jacques Rousseau Pertimbangan-Pertimbangan perihal Pemerintahan Polandia (judul asli dalam bahasa Prancis: Considérations sur le gouvernement de Pologne) adalah sebuah esai yang ditulis pada tahun 1782 oleh filsuf Prancis Jean-Jacques Rousseau perihal rancangan undang-undang dasar baru untuk Persemakmuran Polandia-Lituania. Karya ini merupakan tulisan terakhir Rousseau mengenai teori politik. Rousseau menulis esai ini setelah mendapatkan permintaan dari Michał Wielhorski agar ia member...

 

Louis Ignarro

Questa voce sugli argomenti biochimici e chimici statunitensi è solo un abbozzo. Contribuisci a migliorarla secondo le convenzioni di Wikipedia. Louis J. Ignarro nel 2013 Premio Nobel per la medicina 1998 Louis J. Ignarro (New York, 31 maggio 1941) è un biochimico statunitense. Nel 1998 vinse assieme a Robert Furchgott e Ferid Murad il Premio Nobel per la medicina con la seguente motivazione: «per aver scoperto le implicazioni della molecola di monossido di azoto nel sistema card...

Van Rysselberghe House

Historic Art Nouveau house in Brussels, Belgium Van Rysselberghe HouseMaison Van Rysselberghe (French)Huis Van Rysselberghe (Dutch)General informationTypeTown houseArchitectural styleEclecticism, Art NouveauAddressRue de Livourne / Livornostraat 83Town or city1050 Ixelles, Brussels-Capital RegionCountryBelgiumCoordinates50°49′41″N 4°21′39″E / 50.82806°N 4.36083°E / 50.82806; 4.36083Completed1912Design and constructionArchitect(s)Octave van Rysselb...

 

2012 Finnish presidential election

2012 Finnish presidential election ← 2006 22 January 2012 (first round)5 February 2012 (second round) 2018 → Turnout69.74% (first round)65.98% (second round)   Candidate Sauli Niinistö Pekka Haavisto Party National Coalition Green Popular vote 1,802,328 1,077,425 Percentage 62.59% 37.41% Results by municipalityResults by electoral districtNiinistö:      50–55%      55–60%      60�...

 

Havas

French multinational advertising and public relations company This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (July 2023) (Learn how and when to remove this mes...

Liesbeth Spies

Liesbeth Spies Menteri Dalam Negeri dan Hubungan KerajaanMasa jabatan16 Desember 2011 – 5 November 2012Perdana MenteriMark RuttePendahuluPiet Hein DonnerPenggantiRonald PlasterkKetua partai Christian Democratic AppealMasa jabatan1 November 2010 – 2 April 2011PemimpinLowongPendahuluHenk BlekerPenggantiRuth PeetoomAnggota Dewan PerwakilanMasa jabatan23 Mei 2002 – 17 Juni 2010 Informasi pribadiLahirJantje Wilhelmina Elisabeth Spies06 April 1966 (umur 58)Alph...

 

Grand Prix F1 Belgia 2004

Grand Prix Belgia 2004 Lomba ke-14 dari 18 dalam Formula Satu musim 2004← Lomba sebelumnyaLomba berikutnya → Detail perlombaanTanggal 29 Agustus 2004Nama resmi Formula 1 Belgian Grand Prix 2004[1]Lokasi Circuit de Spa-FrancorchampsSirkuit Fasilitas balap permanenPanjang sirkuit 6.976 km (4.335 mi)Jarak tempuh 44 putaran, 306.927 km (190.716 mi)Cuaca Kering dengan temperatur mencapai 15 °C (59 °F)[2]Posisi polePembalap Jarno Trulli RenaultWak...